<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03692039</url>
  </required_header>
  <id_info>
    <org_study_id>CEBD-CU-2018-09-33</org_study_id>
    <nct_id>NCT03692039</nct_id>
  </id_info>
  <brief_title>Comparison Between M-Pro and ProTaper Next</brief_title>
  <official_title>Comparison of Postoperative Pain After Root Canal Instrumentation Using M-Pro and ProTaper Next in Molars With Symptomatic Irreversible Pulpitis: A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparing the postoperative pain resulting after mechanical instrumentation using M-pro files
      versus that resulting after using ProTaper Next rotary files in lower molar with symptomatic
      Irreversible pulpitis molars.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Lower molars with symptomatic Irreversible pulpitis molars are selected according to the
      eligibility and exclusion criteria and patients are then randomized to receive treatment
      either using M-pro Files or ProTaper Next files. Postoperative pain is then assessed using
      the Numerical Rating scale 6, 12, 24, 48 and 72 hours post-operatively . After completing the
      treatment, patients will instructed to take placebo if they feel pain and will be asked to
      provide the quantity of placebo intake until 72 hrs. In case of pain not relieved by placebo,
      after recording the amount of pain, the patient will be instructed to take an alternative
      line of pain control (Ibuprofen 400mg tablets every 6 hours). The amount and frequency of
      Ibuprofen intake will be recorded.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2018</start_date>
  <completion_date type="Actual">October 1, 2019</completion_date>
  <primary_completion_date type="Actual">October 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Blocks of 4 are generated on a Microsoft Excel sheet where the intervention and control are denoted A &amp; B and randomly distributed. The table is kept with the assistant supervisor.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>After the operator find an eligible participant, a phone call is made to the assistant supervisor to confirm the patient eligibility then to assign the participant to either group according to the generated random sequence.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Post operative pain assessed with numerical rating scale</measure>
    <time_frame>Up to 72 hours post-operatively</time_frame>
    <description>0 (none) to 10 (severe) Numerical Pain Rating Scale up to 72 hours post-operatively</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of placebo intake assessed by questioning</measure>
    <time_frame>Up to 72 hours post-operatively</time_frame>
    <description>Amount of placebo intake up to 72 hours post-operatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of analgesic intake assessed by counting</measure>
    <time_frame>Up to 72 hours post-operatively</time_frame>
    <description>Number of analgesic tablets up to 72 hours post-operatively</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Symptomatic Irreversible Pulpitis</condition>
  <arm_group>
    <arm_group_label>M-pro files</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Instrumentation using M-pro files in rotating motion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ProTaper Next files</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Instrumentation using ProTaper Next files in rotating motion</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>M-pro files in rotating motion</intervention_name>
    <description>An endodontic file that has controlled memory properties</description>
    <arm_group_label>M-pro files</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ProTaper Next files in rotating motion</intervention_name>
    <description>An endodontic file that has an off center mass of rotation</description>
    <arm_group_label>ProTaper Next files</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  1- Males or Females.

          -  2- Mandibular molar teeth with:

               -  Pre-operative sharp pain.

               -  Vital response of pulp tissue to cold pulp tester (ethyl chloride spray).

               -  Normal periapical radiographic appearance or slight widening in lamina dura using
                  periapical index (PAI) score 1 as normal periapical structures or 2 as small
                  changes in bone structures.

        Exclusion Criteria:

          -  Patients having significant systemic disorders.

          -  Patients who are allergic to non-steroidal anti-inflammatory drugs.

          -  Patients with two or more adjacent teeth requiring root canal therapy.

          -  Teeth that have:

               -  Necrotic pulp tissues.

               -  Association with swelling or fistulous tract.

               -  Acute or chronic peri-apical abscess.

               -  Greater than grade I mobility.

               -  Pocket depth greater than 5mm.

               -  No possible restorability.

               -  Previous endodontic treatment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Faculty of Dentistry - Cairo University</name>
      <address>
        <city>Cairo</city>
        <zip>52431</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Koçak MM, Çiçek E, Koçak S, Sağlam BC, Furuncuoğlu F. Comparison of ProTaper Next and HyFlex instruments on apical debris extrusion in curved canals. Int Endod J. 2016 Oct;49(10):996-1000. doi: 10.1111/iej.12552. Epub 2015 Oct 12.</citation>
    <PMID>26383696</PMID>
  </reference>
  <reference>
    <citation>Ruddle CJ, Machtou P, West JD. The shaping movement: fifth-generation technology. Dent Today. 2013 Apr;32(4):94, 96-9.</citation>
    <PMID>23659098</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>September 29, 2018</study_first_submitted>
  <study_first_submitted_qc>October 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 2, 2018</study_first_posted>
  <last_update_submitted>July 13, 2020</last_update_submitted>
  <last_update_submitted_qc>July 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Mohammed Essam Othman Ibrahim</investigator_full_name>
    <investigator_title>Resident at Endodontic department Faculty of Dentistry, Cairo University</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulpitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

